Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $813.40 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $339.46 | 39 | $0 (2024) |
| Lilly USA, LLC | $110.28 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $100.99 | 8 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $93.43 | 7 | $0 (2020) |
| PFIZER INC. | $52.27 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $35.68 | 3 | $0 (2019) |
| AbbVie, Inc. | $16.29 | 1 | $0 (2019) |
| Boston Scientific Corporation | $14.16 | 1 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $13.82 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $13.41 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.66 | 2 | Lilly USA, LLC ($16.77) |
| 2023 | $27.86 | 2 | Boston Scientific Corporation ($14.16) |
| 2022 | $65.70 | 4 | Lilly USA, LLC ($49.37) |
| 2021 | $14.33 | 1 | Novo Nordisk Inc ($14.33) |
| 2020 | $74.43 | 5 | AstraZeneca Pharmaceuticals LP ($34.58) |
| 2019 | $274.29 | 25 | Novo Nordisk Inc ($119.14) |
| 2018 | $147.96 | 21 | Novo Nordisk Inc ($112.56) |
| 2017 | $177.17 | 14 | Novo Nordisk Inc ($51.05) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 12/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 08/01/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/14/2022 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: VACCINES | ||||||
| 10/19/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 09/21/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Diabetes | ||||||
| 06/29/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Diabetes | ||||||
| 05/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 11/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 12/10/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: UROLOGY | ||||||
| 11/22/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/01/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 10/25/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/07/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Diabetes | ||||||
| 09/03/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: DIABETES | ||||||
| 08/29/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Diabetes | ||||||
| 08/26/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
| 08/06/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 215 | 304 | $54,006 | $21,976 |
| 2022 | 7 | 205 | 308 | $52,711 | $20,954 |
| 2021 | 7 | 690 | 932 | $126,168 | $56,370 |
| 2020 | 11 | 726 | 923 | $116,892 | $46,187 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 118 | $23,718 | $10,062 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $11,340 | $4,500 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 71 | $9,656 | $3,978 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,680 | $1,654 | 35.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $2,745 | $1,137 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $1,072 | $478.72 | 44.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 15 | $615.00 | $125.55 | 20.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 18 | $180.00 | $39.60 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 155 | $31,155 | $12,384 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $9,135 | $3,671 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 59 | $8,024 | $3,347 | 41.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 14 | $2,562 | $979.68 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 14 | $938.00 | $396.22 | 42.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 17 | $697.00 | $133.92 | 19.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 20 | $200.00 | $42.13 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 278 | 456 | $79,653 | $34,662 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $16,165 | $8,983 | 55.6% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 79 | 79 | $7,808 | $5,147 | 65.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 104 | $12,400 | $5,017 | 40.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 82 | 82 | $2,408 | $1,298 | 53.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 79 | 127 | $7,466 | $1,233 | 16.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 13 | $268.00 | $29.25 | 10.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 226 | 357 | $62,097 | $21,687 | 34.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 54 | 54 | $12,366 | $6,023 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 112 | 136 | $16,272 | $5,225 | 32.1% |
About Dr. Ryan Allen, DO
Dr. Ryan Allen, DO is a Family Medicine healthcare provider based in Providence, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1689089666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Allen, DO has received a total of $813.40 in payments from pharmaceutical and medical device companies, with $31.66 received in 2024. These payments were reported across 74 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($813.40).
As a Medicare-enrolled provider, Allen has provided services to 1,836 Medicare beneficiaries, totaling 2,467 services with total Medicare billing of $145,487. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Providence, UT
- Active Since 06/27/2014
- Last Updated 12/28/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689089666
Products in Payments
- Ozempic (Drug) $123.29
- Victoza (Drug) $93.97
- FARXIGA (Drug) $82.34
- ANORO (Drug) $51.99
- MOUNJARO (Drug) $51.89
- Tresiba (Drug) $50.73
- TRULICITY (Drug) $44.69
- CHANTIX (Drug) $23.76
- SOLIQUA (Drug) $23.22
- Xultophy 100/3.6 (Drug) $17.76
- PREVNAR 13 (Biological) $16.33
- Synthroid (Drug) $16.29
- Saxenda (Drug) $15.50
- Rybelsus (Drug) $14.89
- WaveWriter Alpha Prime 16 (Device) $14.16
- INCRUSE (Drug) $14.04
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $13.82
- JARDIANCE (Drug) $13.70
- MYRBETRIQ (Drug) $13.41
- STIOLTO (Drug) $12.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Providence
Thomas Clark, Md, MD
Family Medicine — Payments: $325,536
Martin Miner, M.d, M.D
Family Medicine — Payments: $135,113
Dr. Tracey Cohen, M.d, M.D
Family Medicine — Payments: $6,146
Dr. Kevin Duke, D.o, D.O
Family Medicine — Payments: $3,143
Vera Carlson, Md, Phd, MD, PHD
Family Medicine — Payments: $3,017
Kelly Cole, D.o, D.O
Family Medicine — Payments: $2,908